For women aged 50-69, mammography screenings reduce their risk of dying from breast cancer by 40% compared to those who are not screened, claims a study.
"This important analysis will hopefully reassure women around the world that breast screening with mammography saves lives," said Professor Stephen Duffy of Queen Mary University of London. "The evidence proves breast screening is a vital tool in increasing early diagnosis of breast cancer and therefore reducing the number of deaths," Duffy said.
Drug Anastrazole Boosts Long-term Survival After Breast Cancer in Postmenopausal Women
Tamoxifen and anastrazole are both very effective to help prevent breast cancer, but it seems that women have better chances of staying well with anastrazole.
Advertisement
Duffy and experts from 16 countries assessed the positive and negative impact of different breast cancer screening methods, based on a comprehensive analysis of evidence from 11 randomized controlled trials and 40 high-quality observational studies.
"Despite evidence that mammography screening is effective, we still need to carry out further research on alternative screening methods, such as the promising 'digital breast tomosynthesis'; a newly developed form of 3D imaging which could potentially improve the accuracy of mammography in coping with more dense breast tissue," Duffy added.
![New Targeted Therapy may Prolong Health After Advanced Breast Cancer: World Experts]( "New Targeted Therapy may Prolong Health After Advanced Breast Cancer: World Experts")
The targeted drug, palbociclib, was granted accelerated approval by the US Food and Drug Administration for use in women with advanced breast cancer.
The latest findings that looked at breast cancer screening on a global level were coordinated by the International Agency for Research in Cancer (IARC), the World Health Organization's specialized cancer agency, and will contribute to an update of the IARC Handbook on breast cancer screening, last published in 2002.
The study was published in the New England Journal of Medicine.
Source: IANS
New Targeted Therapy may Prolong Health After Advanced Breast Cancer: World Experts
The targeted drug, palbociclib, was granted accelerated approval by the US Food and Drug Administration for use in women with advanced breast cancer.
Advertisement
The latest findings that looked at breast cancer screening on a global level were coordinated by the International Agency for Research in Cancer (IARC), the World Health Organization's specialized cancer agency, and will contribute to an update of the IARC Handbook on breast cancer screening, last published in 2002.
The study was published in the New England Journal of Medicine.
Source: IANS
Removing Extra Tissue During Breast Cancer Surgery Cuts Reoperation Rate by 50%
Thousands of breast cancer patients could be spared a second operation if surgeons removed more tissue around the tumor site during surgery.
Advertisement
 Routine Screening Reduces Risk of Death from Breast Cancer by 40% Compared to OthersMammograms are vital and effective in increasing early diagnosis of breast cancer but researchers are also looking at alternative screening methods. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable